ATE213157T1 - Verwendung von alpha-aminomethyl-3,4- dichlorbenzylthioaceamiden zur herstellung eines dopaminwiederergreifungshemmenden medikaments sowie verbindungen zur verwendung derselben - Google Patents
Verwendung von alpha-aminomethyl-3,4- dichlorbenzylthioaceamiden zur herstellung eines dopaminwiederergreifungshemmenden medikaments sowie verbindungen zur verwendung derselbenInfo
- Publication number
- ATE213157T1 ATE213157T1 AT96401061T AT96401061T ATE213157T1 AT E213157 T1 ATE213157 T1 AT E213157T1 AT 96401061 T AT96401061 T AT 96401061T AT 96401061 T AT96401061 T AT 96401061T AT E213157 T1 ATE213157 T1 AT E213157T1
- Authority
- AT
- Austria
- Prior art keywords
- alpha
- dopamine
- dichlorobenzylthioaceamide
- reapposition
- aminomethyl
- Prior art date
Links
- VYFYYTLLBUKUHU-UHFFFAOYSA-N dopamine Chemical compound NCCC1=CC=C(O)C(O)=C1 VYFYYTLLBUKUHU-UHFFFAOYSA-N 0.000 title abstract 4
- 229960003638 dopamine Drugs 0.000 title abstract 2
- 239000003814 drug Substances 0.000 title abstract 2
- 230000002401 inhibitory effect Effects 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 title 1
- 229940079593 drug Drugs 0.000 title 1
- 239000002253 acid Substances 0.000 abstract 4
- 150000003839 salts Chemical class 0.000 abstract 4
- YUKQRDCYNOVPGJ-UHFFFAOYSA-N thioacetamide Chemical compound CC(N)=S YUKQRDCYNOVPGJ-UHFFFAOYSA-N 0.000 abstract 3
- DLFVBJFMPXGRIB-UHFFFAOYSA-N thioacetamide Natural products CC(N)=O DLFVBJFMPXGRIB-UHFFFAOYSA-N 0.000 abstract 3
- -1 alpha -(1-adamantylaminomethyl)- 3,4-dichlorobenzyl Chemical group 0.000 abstract 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 abstract 1
- 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
- C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
- C07C323/60—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton with the carbon atom of at least one of the carboxyl groups bound to nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2603/00—Systems containing at least three condensed rings
- C07C2603/56—Ring systems containing bridged rings
- C07C2603/58—Ring systems containing bridged rings containing three rings
- C07C2603/70—Ring systems containing bridged rings containing three rings containing only six-membered rings
- C07C2603/74—Adamantanes
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Addiction (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9506000A FR2734264B1 (fr) | 1995-05-19 | 1995-05-19 | Utilisation de derives d'alpha-aminomethyl-3,4-dichlorobenzyl-thioacetamide pour la fabrication d'un medicament inhibant la recapture de la dopamine et nouveaux composes pour cette utilisation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE213157T1 true ATE213157T1 (de) | 2002-02-15 |
Family
ID=9479198
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT96401061T ATE213157T1 (de) | 1995-05-19 | 1996-05-14 | Verwendung von alpha-aminomethyl-3,4- dichlorbenzylthioaceamiden zur herstellung eines dopaminwiederergreifungshemmenden medikaments sowie verbindungen zur verwendung derselben |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US5795915A (de) |
| EP (1) | EP0743063B1 (de) |
| JP (1) | JP3926867B2 (de) |
| KR (1) | KR960041159A (de) |
| AT (1) | ATE213157T1 (de) |
| AU (1) | AU713215B2 (de) |
| CA (1) | CA2176654A1 (de) |
| DE (1) | DE69619156T2 (de) |
| DK (1) | DK0743063T3 (de) |
| ES (1) | ES2172644T3 (de) |
| FR (1) | FR2734264B1 (de) |
| NZ (1) | NZ286602A (de) |
| PT (1) | PT743063E (de) |
| ZA (1) | ZA963846B (de) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH11162829A (ja) * | 1997-11-21 | 1999-06-18 | Nec Corp | 半導体装置の製造方法 |
| EP1148538A4 (de) * | 1998-12-25 | 2009-10-21 | Hitachi Chemical Co Ltd | Cmp-schleifmittel, flüssigzusatz für dasselbe und substratpoliermethode |
| ATE424194T1 (de) | 2001-04-09 | 2009-03-15 | Neurosearch As | Adenosin-a2a-rezeptor-antagonisten in kombination mit verbindungen mit neurotrophischer aktivität bei der behandlung von morbus parkinson |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2561646B1 (fr) * | 1984-03-23 | 1987-10-09 | Lafon Labor | Derives d'acide (a-(alkylaminomethyl)-benzyl)-thioacetique, procede de preparation et utilisation en therapeutique |
| FR2648814B1 (fr) * | 1989-06-26 | 1991-10-18 | Lafon Labor | L'alpha (tert-butyl-aminomethyl-3,4-dichlorobenzyl)thioacetamide, son procede de preparation et son application en therapeutique |
| AU3707601A (en) | 2000-02-08 | 2001-08-20 | Vagas amusment incorperated | Method of and apparatus for operating a video lottery terminal |
-
1995
- 1995-05-19 FR FR9506000A patent/FR2734264B1/fr not_active Expired - Fee Related
-
1996
- 1996-05-14 AT AT96401061T patent/ATE213157T1/de not_active IP Right Cessation
- 1996-05-14 EP EP96401061A patent/EP0743063B1/de not_active Expired - Lifetime
- 1996-05-14 DK DK96401061T patent/DK0743063T3/da active
- 1996-05-14 DE DE69619156T patent/DE69619156T2/de not_active Expired - Fee Related
- 1996-05-14 ES ES96401061T patent/ES2172644T3/es not_active Expired - Lifetime
- 1996-05-14 PT PT96401061T patent/PT743063E/pt unknown
- 1996-05-15 ZA ZA9603846A patent/ZA963846B/xx unknown
- 1996-05-15 CA CA002176654A patent/CA2176654A1/en not_active Abandoned
- 1996-05-16 NZ NZ286602A patent/NZ286602A/en unknown
- 1996-05-17 KR KR1019960016765A patent/KR960041159A/ko not_active Ceased
- 1996-05-17 AU AU52338/96A patent/AU713215B2/en not_active Ceased
- 1996-05-17 US US08/649,530 patent/US5795915A/en not_active Expired - Fee Related
- 1996-05-20 JP JP12498296A patent/JP3926867B2/ja not_active Expired - Fee Related
-
1998
- 1998-05-01 US US09/070,730 patent/US6268397B1/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| US6268397B1 (en) | 2001-07-31 |
| PT743063E (pt) | 2002-07-31 |
| DK0743063T3 (da) | 2002-06-03 |
| DE69619156T2 (de) | 2002-08-14 |
| CA2176654A1 (en) | 1996-11-20 |
| DE69619156D1 (de) | 2002-03-21 |
| US5795915A (en) | 1998-08-18 |
| ZA963846B (en) | 1997-11-17 |
| ES2172644T3 (es) | 2002-10-01 |
| EP0743063A1 (de) | 1996-11-20 |
| FR2734264B1 (fr) | 1997-08-01 |
| JP3926867B2 (ja) | 2007-06-06 |
| FR2734264A1 (fr) | 1996-11-22 |
| NZ286602A (en) | 1997-04-24 |
| JPH093039A (ja) | 1997-01-07 |
| AU713215B2 (en) | 1999-11-25 |
| KR960041159A (ko) | 1996-12-19 |
| AU5233896A (en) | 1996-11-28 |
| EP0743063B1 (de) | 2002-02-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0509368A (pt) | antagonistas cgrp selecionados, processo para a sua fabricação bem como seu uso como medicamento | |
| NO20080789L (no) | 1,4-benzotiazepin 1,1-dioksidderivater, fremgangsmate for fremstilling derav, medikamenter inneholdende denne forbindelsen og anvendelse derav som et hypolipid | |
| IN2015DN01132A (de) | ||
| SE0202429D0 (sv) | Novel Compounds | |
| BR0016611A (pt) | Moduladores de neurotransmissão de dopamina | |
| NO20042161L (no) | Inhibitorer av 11-beta-hydroksysteroid dehydrogenase type 1 | |
| GEP20043269B (en) | Purine Derivatives, Method for Their Production and Composition Containing the Same | |
| MX9203444A (es) | Medicamentos. | |
| EA200500080A1 (ru) | Дозированная форма прамипексола, принимаемая один раз в день | |
| AR034396A1 (es) | Compuestos 4-(1r-4-piperidilen)-4h-benzo[4,5]ciclohepta[1,2]-tiofeno-1-a y sus isomeros opticamente activos, un metodo para su sintesis y el uso de dichos compuestos para la manufactura de un medicamento | |
| NO20045222L (no) | Benzosyrederivater som modulatorer av PPAR alfa og gamma | |
| NO20045486L (no) | Nye forbindelser og deres anvendelse | |
| NO20050217L (no) | Nye quinuklidin-karbamat-derivater samt medisinske sammensetninger inneholdende slike | |
| UA35604C2 (uk) | Фармацевтична композиція з антидепресивною активністю | |
| AR043259A1 (es) | Metodo para el tratamiento de insuficiencia cardiaca severa y medicamento para ello | |
| NO304113B1 (no) | Krystallinsk tiagabinhydrokloridmonohydrat, farmas°ytisk preparat som omfatter det, og anvendelse derav for fremstilling av et medikament | |
| DE602004024417D1 (de) | Neues verfahren zur herstellung von pleuromutilinderivaten | |
| SE9904507D0 (sv) | New compounds | |
| NO20060146L (no) | Benzimidazolderivater, sammensetninger som inneholder slike, fremstilling derav og anvendelse derav | |
| MXPA02012730A (es) | Uso de acido pamoico o uno de sus derivados o uno de sus analogos para la preparacion de un medicamento para el tratamiento de enfermedades caracterizadas por depositos de agregados de amiloide. | |
| ATE213157T1 (de) | Verwendung von alpha-aminomethyl-3,4- dichlorbenzylthioaceamiden zur herstellung eines dopaminwiederergreifungshemmenden medikaments sowie verbindungen zur verwendung derselben | |
| NO20050903L (no) | Nye piperazinyl-pyrazinonderivater for behandling av 5HT-2A reseptorrelaterte forstyrrelser | |
| ATE214051T1 (de) | Substituierte tetrahydropyridinderivate, verfahren zu ihrer herstellung und diese enthaltende arzneimittel | |
| DK0672043T3 (da) | Hidtil ukendte 4-(3-benzofuranyl)-piperidinyl- og 4-(3-benzothienyl)-piperidinyl-derivater og farmaceutiske præparater indeholdende dem | |
| SE0104333D0 (sv) | Therapeutic agents |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |